Core Viewpoint - Green New Bio-Tech (01084) expects to report a net loss attributable to shareholders of approximately RMB 11 million to 13.5 million for the first half of 2025, a significant decline from a net profit of RMB 23.08 million in the same period of 2024 [1] Summary by Relevant Categories Financial Performance - The company anticipates a net loss of approximately RMB 11 million to 13.5 million for the first half of 2025, compared to a net profit of RMB 23.08 million in the first half of 2024 [1] Factors Affecting Performance - The decline in performance is primarily attributed to a decrease in both the selling price and sales volume of the company's main hydrophilic colloid products, leading to reduced revenue and gross profit during the reporting period [1] - There has been an increase in research and development expenses related to the technology and knowledge for producing current mainstream products and new products during the reporting period [1]
绿新生物科技(01084)发盈警 预期上半年公司拥有人应占亏损净额约1100万-1350万元 同比盈转亏